Additionally, we did not only analyze AF recurrence but also outcomes such as changes in cardiac function and BNP levels, hospitalization for HF, and mortality, which are typically assessed as essential endpoints in patients with HF. This evidence concerns the gene NPPB and atrial fibrillation.